Skip to content
Proposals to alter Accelerated Approval would reduce number of new treatments, report finds
Plans to put limits on the FDA’s Accelerated Approval pathway would reduce the number of new treatments hitting the market, with a particularly negative […]
CMS must flesh out plan to ease out-of-pocket drug costs, report says
Provisions in the Inflation Reduction Act (IRA) make it easier for people covered by Medicare Part D to pay for medicine, but continued government
CMS must flesh out plan to ease out-of-pocket drug costs, report says Read More »
U.S. biotech is a major economic driver with a broad range, report says
The U.S. biotech sector is a vital economic engine in all 50 states, providing 2.1 million jobs and a $2.9 trillion impact on the
U.S. biotech is a major economic driver with a broad range, report says Read More »
IRA climate provisions can benefit biotech—and the planet
While the drug pricing provisions of the Inflation Reduction Act (IRA) are expected to kill drug innovation and hamper development of new treatments, the
IRA climate provisions can benefit biotech—and the planet Read More »
HHS probe: Insurer PBMs pocket rebates as patients, taxpayers pay more
The practice of making drug makers give rebates to payers encourages Medicare Part D insurers to steer patients away from generic drugs that cost
HHS probe: Insurer PBMs pocket rebates as patients, taxpayers pay more Read More »
SBIR/STTR seed-funding programs running out of money – and Congress needs to act
Congress needs to ensure the smooth continuation of two federal programs that provide seed funding for small, innovative businesses, according to a host of
SBIR/STTR seed-funding programs running out of money – and Congress needs to act Read More »
Report: State Medicaid policies can interfere with access to new treatments
The patchwork of state regulations regarding Medicaid coverage for new, innovative treatments can create barriers for patients seeking access to the most advanced therapies,
Report: State Medicaid policies can interfere with access to new treatments Read More »
Efforts at value-based care focus on patients’ needs
What is the value of a treatment? As of July, the U.S. government has given out close to 600 million doses of COVID-19 vaccines
Efforts at value-based care focus on patients’ needs Read More »
We have monkeypox treatments – but must act fast
In the battle against the current monkeypox outbreak, humanity seems to be ahead of where we were when COVID-19 first appeared. Smallpox solutions already
We have monkeypox treatments – but must act fast Read More »
PDUFA panelists praise FDA’s cooperation on setting drug approval process
The draft of the next Food and Drug Administration (FDA) user fee agreement currently making its way through Congress was developed with close cooperation
PDUFA panelists praise FDA’s cooperation on setting drug approval process Read More »